Abstract
Therapeutics in alopecia areata (AA) have remained relatively unchanged for many years, with few treatments having more than moderate effects in severely affected patients. The advent of the new biologic medications in the dermatologic world, however, particularly in psoriasis treatment, introduces possibilities of treatment for many other immune-mediated diseases.
MeSH terms
-
Alefacept
-
Alopecia Areata / therapy*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Humans
-
Immunologic Factors / therapeutic use*
-
Psoriasis / therapy*
-
Recombinant Fusion Proteins / therapeutic use
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunologic Factors
-
Recombinant Fusion Proteins
-
Tumor Necrosis Factor-alpha
-
Alefacept
-
efalizumab